Avidity Partners Management LP

Position in VIR — Vir Biotechnology, Inc.

CIK 1791827 DALLAS, TX

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,291,667

-$257,261 QoQ

Shares Held

519,300

-16.1% QoQ

Ownership

0.307%

of shares outstanding

% of Portfolio

0.85%

of 13F equity value

Holder Rank

#45

of 237 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Avidity Partners Management LP holds $524,784,316 across 27 Biotechnology names. VIR ranks #10 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DNTH	Dianthus Therapeutics, Inc. /DE/	2,104,184	$205,115,856
2	CGON	CG Oncology, Inc.	1,398,948	$99,395,255
3	ORKA	Oruka Therapeutics, Inc.	760,424	$72,369,552
4	JBIO	Jade Biosciences, Inc.	1,700,708	$37,789,731
5	ELVN	Enliven Therapeutics, Inc.	550,000	$27,912,500
6	AKTS	Aktis Oncology, Inc.	484,200	$15,605,766
7	PVLA	Palvella Therapeutics, Inc.	70,000	$10,697,400
8	IMUX	Immunic, Inc.	669,941	$10,296,993

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,291,667	519,300	-16.1%	Shares	Sole	2026-08-14
2026-03-31	$5,548,928	619,300	-56.5%	Shares	Sole	2026-05-13
2023-06-30	$34,955,250	1,425,000	-13.1%	Shares	Sole	2023-08-14
2023-03-31	$38,167,454	1,640,200	+93.0%	Shares	Sole	2023-05-15
2022-12-31	$21,513,500	850,000	+12.1%	Shares	Sole	2023-02-14
2022-06-30	$19,311,634	758,211	-2.8%	Shares	Sole	2022-08-15
2022-03-31	$20,061,600	780,000	+11.4%	Shares	Sole	2022-05-16
2021-12-31	$29,309,000	700,000	+35.9%	Shares	Sole	2022-02-14
2021-09-30	$22,412,800	515,000	+217.9%	Shares	Sole	2021-11-15
2021-06-30	$7,659,360	162,000	-73.9%	Shares	Sole	2021-08-16
2020-06-30	$25,425,982	620,600	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.